Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.790
+0.125 (7.51%)
Sep 5, 2025, 4:00 PM - Market closed
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $12.64 million as of September 5, 2025. Its market cap has increased by 29.72% in one year.
Market Cap
12.64M
Enterprise Value
-1.00M
1-Year Change
29.72%
Ranking
Category
Stock Price
1.79
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $12.64M, a decrease of -96.91%. That is a compound annual growth rate of -24.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 11.76M | -63.55% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | 86.15M | 123.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |